Chicago Medical School, Naperville, and Veterans Affairs Medical Center, North Chicago, IL 60064, USA.
Am J Ther. 2010 Mar-Apr;17(2):e48-51. doi: 10.1097/01.mjt.0000369908.44628.89.
The association between hyperglycemia and increased mortality associated with acute coronary syndrome (ACS) has been studied and affirmed. Although more studies are needed to explore how managing this hyperglycemia can affect ACS mortality, the need to educate regarding current data is urgent so that it can be clinically applied. Reviews, randomized controlled trials, and other studies were obtained by means of electronic search strategies, such as Medline and Cochrane Library, as well as hand selection. Sources selected were limited to those that discussed ACS and hyperglycemia, and specific emphasis was placed on sources that focused on ACS and hyperglycemia in conjunction with one another. Selected studies were then assessed for quality and relevance. Clear correlations between mean and persistent glucose levels and ACS mortality are found. Persistent glucose levels offer a better model to predict ACS mortality than on-admission glucose levels. However, findings concerning the effect on ACS-related mortality of controlling glucose levels have been conflicting.
高血糖与急性冠状动脉综合征(ACS)相关死亡率增加之间的关联已被研究和证实。尽管需要更多的研究来探讨如何控制这种高血糖可以影响 ACS 死亡率,但紧急需要教育相关的最新数据,以便能够在临床上应用。通过电子搜索策略(如 Medline 和 Cochrane Library)以及手动选择,获得了综述、随机对照试验和其他研究。选择的来源仅限于那些讨论 ACS 和高血糖的研究,并特别强调了那些专注于 ACS 和高血糖相互结合的研究。然后评估了选定的研究的质量和相关性。发现平均血糖水平和持续血糖水平与 ACS 死亡率之间存在明显的相关性。持续血糖水平比入院时血糖水平提供了更好的预测 ACS 死亡率的模型。然而,关于控制血糖水平对 ACS 相关死亡率的影响的研究结果存在冲突。